Adrenomedullin peptides

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameAdrenomedullin peptides
Drug Alias NamePO70PO71PO72
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAdrenomedullin receptor agonistsBone resorption inhibitors
TargetsAdrenomedullin receptor
Therapy Area/IndicationsWounds and InjuriesDiabetes Mellitus, Type 2Hematologic Diseases +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesDiabetes Mellitus, Type 2Hematologic Diseases +[7

Other Information

ATC CodeN/A
Related LinksN/A